65259-81-6 - China Manufacturers, Suppliers, Factory

65259-81-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

(-)-Dipivaloyl-L-Tartaric Acid CAS 65259-81-6 Purity ≥98.0% (HPLC) Factory High Quality
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...

2022.12.26 02:36:28
2022.11.13 04:16:09
2022.06.15 23:54:44
2022.05.29 23:18:12
2022.04.26 23:53:31
2021.10.16 05:27:16

65259-81-6 - China Manufacturers, Suppliers, Factory

Related Products

(-)-Dipivaloyl-L-Tartaric Acid CAS 65259-81-6 Purity ≥98.0% (HPLC) Factory High Quality

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

5-Nitroindole CAS 6146-52-7 Purity >99.0% (HPLC) Factory High Quality

Ethylene Carbonate (EC) CAS 96-49-1 Purity >99.9% (GC) Factory High Quality

Fmoc-Tyr-OH CAS 92954-90-0 Fmoc-L-Tyrosine Purity >98.5% (HPLC) Factory

Entecavir Monohydrate CAS 209216-23-9 API Factory High Quality Antiviral Hepatitis B Infection

N-Benzoyl-L-Alanine CAS 2198-64-3 (Bz-Ala-OH) Assay >98.0% (TLC)

Acotiamide Hydrochloride Trihydrate CAS 773092-05-0 API Manufacturer High Purity

H-Asp-OMe CAS 17812-32-7 L-Aspartic Acid α-Methyl Ester Purity >98.5% (TLC)

H-Leu-OBzl·TosOH CAS 1738-77-8 L-Leucine Benzyl Ester p-Toluenesulfonate Salt Purity >99.0% (HPLC) Factory

Fmoc-D-Phg-OH CAS 111524-95-9 Purity >98.0% (HPLC) Factory

Pyrazole CAS 288-13-1 Purity >99.5% (HPLC) Factory

1-Dodecylpyridinium Chloride CAS 104-74-5 Purity ≥99.0% Factory

Ethyl 4-Nitrophenylacetate CAS 5445-26-1 Purity ≥98.0% (HPLC) Factory

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Method Of Analyzing Palladium Content In Palladium Catalysts

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

New COVID treatments offer hope

The “Summit on COVID-19 Diagnostics & Treatment”

2022.12.26 02:36:28

2022.11.13 04:16:09

2022.06.15 23:54:44

2022.05.29 23:18:12

2022.04.26 23:53:31

2021.10.16 05:27:16

related search